Literature DB >> 2271264

Experiences of patients with false positive results from colorectal cancer screening.

D Mant1, R Fitzpatrick, A Hogg, A Fuller, A Farmer, J Verne, J Northover.   

Abstract

A survey was conducted to study the experiences of patients with false positive results for colorectal cancer. The study patients were participants in a randomized trial of compliance with different methods of colorectal cancer screening by faecal occult blood testing. Fifty four out of fifty six patients (96.4%) with false positive results agreed to be interviewed. An age and sex matched control group of 112 patients with negative test results was identified --92 (82.1%) returned questionnaires. Thirteen of the patients with false positive results (24.1%) and 19 controls (20.7%) were to some extent distressed by the initial letter inviting them to participate in the screening programme. Thirty seven of the patients with false positive results (68.5%) felt some degree of distress at the initial positive test result and 19 (35.2%) some distress because of delays experienced in the process of being screened. Ten false positive patients had colonoscopy and the median waiting time for this procedure was 10 days--half of the patients found this wait distressing. Nevertheless, 53 of the patients with false positive results (98.1%) felt that it had been worthwhile to have had the test. Generally, colorectal screening was as acceptable to the patients who experienced false positive results as to those with negative results.

Entities:  

Mesh:

Year:  1990        PMID: 2271264      PMCID: PMC1371385     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  9 in total

Review 1.  Psychological costs of screening.

Authors:  T M Marteau
Journal:  BMJ       Date:  1989-08-26

Review 2.  Participation in fecal occult blood screening: a critical review.

Authors:  S J Blalock; B M DeVellis; R S Sandler
Journal:  Prev Med       Date:  1987-01       Impact factor: 4.018

3.  Screening for Down's syndrome.

Authors:  T M Marteau; J Kidd; R Cook; M Johnston; S Michie; R W Shaw; J Slack
Journal:  BMJ       Date:  1988-12-03

4.  Can health screening damage your health?

Authors:  H G Stoate
Journal:  J R Coll Gen Pract       Date:  1989-05

5.  The value of screening.

Authors:  R R Love; A E Camilli
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

6.  Hypertension labeling and sense of well-being.

Authors:  J R Bloom; S Monterossa
Journal:  Am J Public Health       Date:  1981-11       Impact factor: 9.308

7.  Occult-blood screening for colorectal carcinoma: the risks.

Authors:  J W Frank
Journal:  Am J Prev Med       Date:  1985 Jul-Aug       Impact factor: 5.043

Review 8.  Detection and surveillance of colorectal cancer.

Authors:  D E Fleischer; S B Goldberg; T H Browning; J N Cooper; E Friedman; F H Goldner; E B Keeffe; L E Smith
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

Review 9.  Occult-blood screening for colorectal carcinoma: the benefits.

Authors:  J W Frank
Journal:  Am J Prev Med       Date:  1985 May-Jun       Impact factor: 5.043

  9 in total
  12 in total

Review 1.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

2.  Primary care visit use after positive fecal immunochemical test for colorectal cancer screening.

Authors:  Grace Clarke Hillyer; Christopher D Jensen; Wei K Zhao; Alfred I Neugut; Benjamin Lebwohl; Jasmin A Tiro; Lawrence H Kushi; Douglas A Corley
Journal:  Cancer       Date:  2017-06-16       Impact factor: 6.860

3.  Acceptability of opportunistic screening for occult gastrointestinal blood loss.

Authors:  F D Hobbs; R C Cherry; J W Fielding; L Pike; R Holder
Journal:  BMJ       Date:  1992-02-22

4.  Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

5.  Screening for colorectal neoplasia: physicians' adherence to complete diagnostic evaluation.

Authors:  R E Myers; A M Balshem; T A Wolf; E A Ross; L Millner
Journal:  Am J Public Health       Date:  1993-11       Impact factor: 9.308

6.  Screening for colorectal cancer.

Authors:  J Austoker
Journal:  BMJ       Date:  1994-08-06

7.  Factors affecting women's response to an invitation to attend for a second breast cancer screening examination.

Authors:  M Orton; R Fitzpatrick; A Fuller; D Mant; C Mlynek; M Thorogood
Journal:  Br J Gen Pract       Date:  1991-08       Impact factor: 5.386

Review 8.  Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.

Authors:  Ganepola Ap Ganepola; Joel Nizin; John R Rutledge; David H Chang
Journal:  World J Gastrointest Oncol       Date:  2014-04-15

9.  Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system.

Authors:  Sharon S Laing; Andy Bogart; Jessica Chubak; Sharon Fuller; Beverly B Green
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-12       Impact factor: 4.254

10.  The OxVALVE population cohort study (OxVALVE-PCS)-population screening for undiagnosed valvular heart disease in the elderly: study design and objectives.

Authors:  Sean Coffey; Joanna L d'Arcy; Margaret A Loudon; David Mant; Andrew J Farmer; Bernard D Prendergast
Journal:  Open Heart       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.